Yardley, PA, United States of America

Mark S Bednarz


 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Yardley, PA (US) (2011 - 2014)
  • Lower Makefield Township, PA (US) (2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Mark S Bednarz

Introduction

Mark S Bednarz is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work primarily focuses on the development of crystalline solid forms and methods of synthesis for various compounds.

Latest Patents

Among his latest patents, Bednarz has developed crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis. Additionally, he has disclosed methods of preparing solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and salts thereof.

Career Highlights

Mark S Bednarz is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in the synthesis of complex compounds has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Bednarz has collaborated with notable colleagues such as Ramanaiah C Kanamarlapudi and Wenxue Wu. These collaborations have further enhanced the scope and impact of his research.

Conclusion

Mark S Bednarz is a distinguished inventor whose work in pharmaceuticals has led to multiple patents and significant advancements in drug development. His contributions continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…